EarningsQ2 2024 Earnings Report

Nektar Therapeutics (ITH0) Q2 2024 Earnings Report

1 Followers

DE:ITH0 Q2 2024 EPS Results

Actual EPS-€3.31

Consensus EPS-€2.45

Beat/MissMissed by -€0.86

One Year Ago EPS-€3.58

Actual Revenue€20.74M

Expected Revenue€16.07M

Beat/MissBeat by +€4.67M

YoY Revenue Growth+14.59%

QuarterQ2 2024

Date08/08/2024

TimeAfter Close

Conference CallThursday, August 8, 2024

DE:ITH0 Upcoming Earnings

Nektar Therapeutics's next earnings date is estimated for November 5, 2026, based on past reporting schedules.

DE:ITH0 Q2 2024 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 05, 2026	2026 (Q3)	-1.85 / -	-1.651	―
Aug 13, 2026	2026 (Q2)	-1.74 / -1.09	-2.604	58.31% (+1.52)
May 07, 2026	2026 (Q1)	-1.40 / -1.61	-3.178	49.44% (+1.57)
Mar 12, 2026	2025 (Q4)	-2.18 / -1.57	0.397	-495.56% (-1.97)
Nov 06, 2025	2025 (Q3)	-2.37 / -1.65	-2.384	30.74% (+0.73)
Aug 07, 2025	2025 (Q2)	-2.67 / -2.60	-3.31	21.33% (+0.71)
May 08, 2025	2025 (Q1)	-2.26 / -3.18	-2.516	-26.32% (-0.66)
Mar 12, 2025	2024 (Q4)	-1.80 / 0.40	-2.913	113.64% (+3.31)
Nov 07, 2024	2024 (Q3)	-2.64 / -2.38	-3.178	25.00% (+0.79)
Aug 08, 2024	2024 (Q2)	-2.45 / -3.31	-3.575	7.41% (+0.26)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed